Corporate Governance

Mr. FENG Dai (馮岱), aged 49, is our chairman of the Board and a non-executive Director, appointed in November 2018, and is primarily responsible for overall strategy planning, corporate governance and business direction of our Group. Mr. Feng has been appointed as the chairman of the Nomination Committee, effective from June 16, 2021. Mr. Feng joined our Group in May 2012.

Mr. Feng is the co-founder and managing director of CareCapital Advisors since March 2015. CareCapital is a leading investor in oral health with a broad portfolio of dental technology and service companies worldwide. He also serves as directors in the portfolio companies of CareCapital, including in the areas of orthodontics, implants and bone regeneration. He also serves in a number of non-profit organizations devoted to dentistry, including as the co-chairman of the board of International Orthodontics Foundation Limited, a not-for-profit international research and education organization devoted to improving orthodontic care worldwide, and as a member of the Board of Fellows of Harvard School of Dental Medicine. Mr. Feng served as an independent director of Wuxi Apptec, a CRO company listed on the Stock Exchange (stock code: 02359) and the Shanghai Stock Exchange (stock code: 603259), from December 2018 to January 2025. From December 2017 to August 2024, he served as an independent director of Sling Group Holdings Limited, a company listed on the Stock Exchange (stock code: 08285). From April 2004 to December 2014, he served various positions, including associate, principal and managing director at Warburg Pincus, a leading global private equity firm.

Mr. Feng graduated from Harvard University with a bachelor’s degree in engineering sciences in June 1997.

Mr. Hu Jiezhang (胡杰章), aged 50, is our executive Director, chief executive officer and chief technology officer, and is primarily responsible for the overall strategic planning and daily operations of our Group, including promoting the development of our digital technology. Mr. Hu joined our Group and was appointed as a non-executive Director in December 2020, and was re-designated and appointed as an executive Director, a member of the Remuneration Committee and the chief executive officer with effect from July 2023.

Mr. Hu has served as a venture partner and managing director of CareCapital Advisors Limited, a leading investor in oral health with a broad portfolio of dental technology and service companies worldwide since January 2018. Mr. Hu currently serves as non-executive chairman of Shanghai CareCapital Dental Devices Co., Ltd., a leading distribution group of dental products based out of China. Prior to that, Mr. Hu was a vice president at Zoom Commerce Ltd. from June 2016 to January 2018. Mr. Hu also served as a vice president at Beyondsoft Corporation, a company listed on the Shenzhen Stock Exchange (stock code: 002649), from December 2012 to May 2016. Mr. Hu also worked for several other companies, including served as a vice president at Achievo Information Technology (Shenzhen) Co., Ltd. from May 2007 to November 2012, as a general manager at Guangzhou Jie’ao Computer Technology Co., Ltd. from February 2003 to April 2007, and as a technical director at Zoom Commerce Ltd. from November 1999 to January 2003.

Mr. Hu graduated from Nanjing University with a bachelor’s degree in applied physics in July 1995. 

Mr. Huang Kun (黃琨), aged 42, is our executive Director and the president of our non-China global business, and is primarily responsible for the non-China global business operation and expansion of our Group. Mr. Huang joined our Group in January 2015 and was appointed as a non-executive Director in November 2018 and a member of the Remuneration Committee in June 2021, and was re-designated and appointed as an executive Director and the president of our non-China global business with effect from September 2023.

Mr. Huang joined CareCapital Advisors in April 2015 as the co-founder and a managing director. CareCapital is a leading investor in oral health with a broad portfolio of dental technology and service companies worldwide. Mr. Huang is the co-chairman of the board of International Orthodontics Foundation Limited, a not-for-profit research and education organization devoted to improving orthodontic care worldwide, and a director of Purgo Biologics, a bone regenerative materials company based in Seoul. Prior to that, Mr. Huang served as a vice president of Warburg Pincus from July 2011 to March 2015 and as a senior investment manager of Orchid Asia Investment Consulting (Shanghai) Co., Ltd. from June 2007 to June 2011.

Mr. Huang graduated from Tsinghua University with a bachelor’s degree in finance in July 2005.

Mr. Song Xin (宋鑫), aged 38, is our executive Director and Chief Strategy Officer, and is primarily responsible for the Company’s medium- to long-term strategic planning, implementation of key strategic projects, leading innovation initiatives and driving synergies across the Company’s investment portfolio companies. Mr. Song joined our Group in August 2011, and has served as an executive Director since April 2021, the Chief Commercial Officer from February 2018 to Septemper 2023, the Chief Operating Officer from Septemper 2023 to October 2025 and the Chief Strategy Officer since November 1, 2025.

Prior to joining our Group, Mr. Song had served as a regional manager at Guizhou Tongjitang Pharmaceutical Co., Ltd. from March 2009 to July 2011.

Mr. Song graduated from Henan University of Technology with his bachelor’s degree in bio-technology in July 2008, and graduated from Fudan University with an EMBA degree in July  2024.

Ms. Dong Li (董莉), aged 54, is our executive Director and chief financial officer, and is primarily responsible for all aspects of the Group’s financial operations, including accounting, financial planning, reporting and analysis, business decision support, tax, internal control, treasury and investor relations. Ms. Dong has been appointed as our independent non-executive Director since May 2021, and was re-designated as an executive Director and appointed as the chief financial officer with effect from April 2023. Ms. Dong has also served as a director of Aditek, a leading manufacturer of orthodontic products in Brazil, since April 2025.

Ms. Dong has been an independent non-executive director at Yixin Group Limited, a company listed on the Stock Exchange (stock code: 2858), since November 2017. She was also an independent non-executive director of Telink Semiconductor (Shanghai) Co., Ltd., a company listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange (Stock Code: 688591), from January 2021 to December 2023, and an independent nonexecutive director of 58.com Inc., a company previously listed on the New York Stock Exchange (ticker: WUBA), from April 2020 to September 2020. Prior to that, Ms. Dong served as a chief financial officer and executive director at RDA Microelectronics, Inc., a company previously listed on NASDAQ (ticker: RDA), from November 2007 to July 2015. Ms. Dong worked for Hewlett-Packard in China since 1992, and was the Finance Operations Manager of Hewlett-Packard Technology (Shanghai) Co., Ltd. when she left in 2005.

Ms. Dong graduated from Nanjing University of Science and Technology with a bachelor’s degree in economics in July 1992. She further obtained an MBA degree from China Europe International Business School in April 2004. She is an accountant recognized by the Ministry of Finance of the PRC in October 1994.

Mr. HAN Xiaojing (韓小京), aged 70, is our independent non-executive Director, and is primarily responsible for supervising and providing independent opinion to our Board. Mr. Han has been appointed as our independent nonexecutive Director since May 2021. Mr. Han has been appointed as the chairman of the Remuneration Committee and a member of the Audit Committee and the Nomination Committee, respectively, effective from June 16, 2021.

Mr. Han is the founding partner of Commerce & Finance Law Offices and has been an attorney there since May 1992. Mr. Han is admitted to practicing law in the PRC and has more than 30 years of experience in the legal profession. Mr. Han has also been an independent non-executive director at Sino-Ocean Group Holding Limited, a real estate company listed on the Stock Exchange (stock code: 3377), Far East Horizon Limited, a company listed on the Stock Exchange (stock code: 3360) and Vital Mobile Holdings Limited, a company listed on the Stock Exchange (stock code: 6133), since June 2007, March 2011 and June 2019, respectively. He has also served as a supervisor at Ping An Bank Company Limited, a company listed on the Shenzhen Stock Exchange (stock code: 000001), since October 2020 and served as one of its independent directors from February 2014 to October 2020. Prior to that, he served as an independent director of Beijing Haixin Energy Technology Co., Ltd. (formerly known as Beijing Sanju Environmental Protection & New Materials Company Limited), a company listed on the Shenzhen Stock Exchange (stock code: 300072), from April 2014 to September 2020, and as an outside director of China National Aviation Fuel Group Limited, a Chinese state-owned enterprise in 2016 Fortune Global 500 list, from December 2017 to January 2024.

Mr. Han graduated from Hubei Finance College (currently known as Zhongnan University of Economics and Law) with a bachelor’s degree in law in July 1982. He further obtained a master’s degree in law from China University of Political Science and Law in July 1985.

Mr. Mr. SHI Zi (石子), aged 55, is our independent non-executive Director, and is primarily responsible for supervising and providing independent opinion to our Board. Mr. Shi has been appointed as our independent non-executive Director since May 2021. Mr. Shi has been appointed as a member of the Audit Committee, the Remuneration Committee and the Nomination Committee, respectively, effective from June 16, 2021.

Mr. Shi has been the executive director and general manager of Shenzhen Qianhai E-Cloud Technology Company Limited since January 2015. He also worked as a senior partner at Junsan Capital Management Company Limited from September 2009 to September 2014 and a vice president of the group at SF Express (Group) Company Limited from July 2007 to November 2009. Prior to that, Mr. Shi served as the director of the information technology department and the director of factory affairs at Hitachi Global Storage Technologies (Shenzhen) Company Limited (formerly known as Shenzhen IBM Technology Products Company Limited) from January 1999 to July 2007.

Mr. Shi graduated from Tsinghua University with a bachelor’s degree in electrical engineering in July 1993. He further obtained a master’s degree in business administration from Tsinghua Shenzhen International Graduate School in July 2006.

Mr. ZHOU Hao (周浩)，aged 48, is our independent non-executive Director, and is primarily responsible for supervising and providing independent opinion to our Board. Mr. Zhou has been appointed as our independent nonexecutive Director, the chairman of the Audit Committee and a member of each of the Nomination Committee and Remuneration Committee since April 2023.

Mr. Zhou has served as an independent non-executive director of WuXi XDC Cayman Inc., a company listed on the Stock Exchange (stock code: 2268) since November 2023, an independent non-executive director of Bairong Inc., a company listed on the Stock Exchange (stock code: 6608) since March 2021, and an independent non-executive director of Meitu, Inc., a company listed on the Stock Exchange (stock code: 1357) since November 2016. 

From June 2011 to September 2019, Mr. Zhou was the chief financial officer of 58.com Inc., (NYSE: WUBA), a company that operates online marketplace serving local merchants and consumers in the PRC, and was subsequently redesignated as the head of international business in September 2019 and the chief strategic officer in April 2020. In November 2020, he was redesignated as the chief strategy officer of Anjuke, the housing subsidiary of 58.com Inc. and served the role until March 2023. Prior to that, in September 2010, Mr. Zhou joined CITIC Pharmaceutical Co Ltd., a pharmaceutical service provider that supplies medicine and related consumables to hospitals as the chief financial officer. From May 2009 to September 2010, Mr. Zhou was the vice president of finance and the chief financial officer at Wuxi PharmaTech (Cayman) Inc., (NYSE: WX). Before then, in January 2007, Mr. Zhou joined General Electric (China) Co., Ltd. as a financial manager.

Mr. Zhou received his bachelor’s degree from Shanghai International Studies University in July 1998.

Mr. HU Jiezhang (胡杰章), aged 50, is our executive Director, chief executive officer and chief technology officer, and is primarily responsible for the overall strategic planning and daily operations of our Group, including promoting the development of our digital technology. Mr. Hu joined our Group and was appointed as a non-executive Director in December 2020, and was re-designated and appointed as an executive Director, a member of the Remuneration Committee and the chief executive officer with effect from July 2023.

Mr. Hu has served as a venture partner and managing director of CareCapital Advisors Limited, a leading investor in oral health with a broad portfolio of dental technology and service companies worldwide since January 2018. Mr. Hu currently serves as non-executive chairman of Shanghai CareCapital Dental Devices Co., Ltd., a leading distribution group of dental products based out of China. Prior to that, Mr. Hu was a vice president at Zoom Commerce Ltd. from June 2016 to January 2018. Mr. Hu also served as a vice president at Beyondsoft Corporation, a company listed on the Shenzhen Stock Exchange (stock code: 002649), from December 2012 to May 2016. Mr. Hu also worked for several other companies, including served as a vice president at Achievo Information Technology (Shenzhen) Co., Ltd. from May 2007 to November 2012, as a general manager at Guangzhou Jie’ao Computer Technology Co., Ltd. from February 2003 to April 2007, and as a technical director at Zoom Commerce Ltd. from November 1999 to January 2003.

Mr. Hu graduated from Nanjing University with a bachelor’s degree in applied physics in July 1995.

Mr. HUANG Kun (黃琨), Mr. HUANG Kun (黃琨), aged 42, is our executive Director and the president of our non-China global business, and is primarily responsible for the non-China global business operation and expansion of our Group. Mr. Huang joined our Group in January 2015 and was appointed as a non-executive Director in November 2018 and a member of the Remuneration Committee in June 2021, and was re-designated and appointed as an executive Director and the president of our non-China global business with effect from September 2023.

Mr. Huang joined CareCapital Advisors in April 2015 as the co-founder and a managing director. CareCapital is a leading investor in oral health with a broad portfolio of dental technology and service companies worldwide. Mr. Huang is the co-chairman of the board of International Orthodontics Foundation Limited, a not-for-profit research and education organization devoted to improving orthodontic care worldwide, and a director of Purgo Biologics, a bone regenerative materials company based in Seoul. Prior to that, Mr. Huang served as a vice president of Warburg Pincus from July 2011 to March 2015 and as a senior investment manager of Orchid Asia Investment Consulting (Shanghai) Co., Ltd. from June 2007 to June 2011.

Mr. Huang graduated from Tsinghua University with a bachelor’s degree in finance in July 2005.

Mr. Song Xin (宋鑫), aged 38, is our executive Director and Chief Strategy Officer, and is primarily responsible for the Company’s medium- to long-term strategic planning, implementation of key strategic projects, leading innovation initiatives and driving synergies across the Company’s investment portfolio companies. Mr. Song joined our Group in August 2011, and has served as an executive Director since April 2021, the Chief Commercial Officer from February 2018 to Septemper 2023, the Chief Operating Officer from Septemper 2023 to October 2025 and the Chief Strategy Officer since November 1, 2025.

Prior to joining our Group, Mr. Song had served as a regional manager at Guizhou Tongjitang Pharmaceutical Co., Ltd. from March 2009 to July 2011.

Mr. Song graduated from Henan University of Technology with his bachelor’s degree in bio-technology in July 2008, and graduated from Fudan University with an EMBA degree in July  2024.

Ms. DONG Li (董莉), aged 54, is our executive Director and chief financial officer, and is primarily responsible for all aspects of the Group’s financial operations, including accounting, financial planning, reporting and analysis, business decision support, tax, internal control, treasury and investor relations. Ms. Dong has been appointed as our independent non-executive Director since May 2021, and was re-designated as an executive Director and appointed as the chief financial officer with effect from April 2023. Ms. Dong has also served as a director of Aditek, a leading manufacturer of orthodontic products in Brazil, since April 2025.

Ms. Dong has been an independent non-executive director at Yixin Group Limited, a company listed on the Stock Exchange (stock code: 2858), since November 2017. She was also an independent non-executive director of Telink Semiconductor (Shanghai) Co., Ltd., a company listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange (Stock Code: 688591), from January 2021 to December 2023, and an independent nonexecutive director of 58.com Inc., a company previously listed on the New York Stock Exchange (ticker: WUBA), from April 2020 to September 2020. Prior to that, Ms. Dong served as a chief financial officer and executive director at RDA Microelectronics, Inc., a company previously listed on NASDAQ (ticker: RDA), from November 2007 to July 2015. Ms. Dong worked for Hewlett-Packard in China since 1992, and was the Finance Operations Manager of Hewlett-Packard Technology (Shanghai) Co., Ltd. when she left in 2005.

Ms. Dong graduated from Nanjing University of Science and Technology with a bachelor’s degree in economics in July 1992. She further obtained an MBA degree from China Europe International Business School in April 2004. She is an accountant recognized by the Ministry of Finance of the PRC in October 1994.

Mr. (Richard Hirschland), aged 63, is our senior vice president and global chief commercial officer, and is primarily responsible for commercial operations of our Group outside of China. Mr. Hirschland participated in our business operation as an advisor since January 2023, and joined our Group in August 2024. Mr. Hirschland has also served as a director of Aditek, a leading manufacturer of orthodontic products in Brazil, since April 2025.

Mr. Hirschland has more than 25 years of experience in global commercial operations in oral healthcare industries. Prior to joining our Group, from January 2019 to June 2020, Mr. Hirschland worked as vice-president and general manager, imaging business unit at Envista (NYSE: NVST), a company focusing on provision of oral healthcare related services and products, which spun off from Danaher Corporation (NYSE: DHR), a conglomerate with a focus on biotechnology, diagnostics, and life sciences businesses. From 2016 to 2019, and from 2020 to 2023 Mr. Hirschland served as a senior advisor to CareCapital and Carlyle, which are global private equity firms, working on oral healthcare related projects, respectively. From 2007 to 2015, Mr. Hirschland served as the president of the Carestream Dental Division of Carestream Health, Inc., a global business comprised of digital equipment, practice management software and consumables. Prior to that, from 1983 to 2007, Mr. Hirschland worked in a number of areas including the dental business for Eastman Kodak Company, with his last position being a corporate vice president.

Mr. Hirschland graduated from Cornell University with a bachelor’s degree in operations research in May 1983, and obtained a master’s degree in engineering from Cornell University in August 1993.